Other Helpful Resources


TERAVOLT: Thoracic cancERs international coVid 19 cOLlaboraTion registry for thoracic cancers

The global TERAVOLT registry, initiated in March 2020, aims to provide outcome data specific to patients with thoracic cancer who contracted coronavirus. The data collected will hopefully guide disease management and define factors influencing associated morbidity and mortality.

Other cancer registries: